Author:
Bhatt Himanshu N.,Diwan Rimpy,Estevao Igor L.,Dong Rui,Smith Jennifer,Xiao Chuan,Agarwal Sandeep K.,Nurunnabi Md
Funder
National Institutes of Health Office of the Director
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Reference56 articles.
1. Pathogenesis of Systemic Sclerosis: Recent Insights of Molecular and Cellular Mechanisms and Therapeutic Opportunities - John Varga, Maria Trojanowska, Masataka Kuwana, 2017, (n.d.). https://doi.org/10.5301/jsrd.5000249 (accessed November 29, 2023).
2. Emerging targets of disease-modifying therapy for systemic sclerosis Nat. Rev. Rheumatol., (n.d.). https://www.nature.com/articles/s41584-019-0184-z (accessed November 29, 2023).
3. Scleroderma Facts, n.d. https://scleroderma.org/wp-content/uploads/2022/02/SIP-2022-Updated-7_5_2022.pdf.
4. Scleroderma: from cell and molecular mechanisms to disease models;Abraham;Trends Immunol.,2005
5. New molecular medicine-based scar management strategies;Arno;Burns,2014